One parent company. Multiple healthcare technology lines.
Cloven Technology Impilo owns Ambulant+, CarePort, MedReach, InsightCore, DueCare and MediRun. Ambulant+ is the Contactless Medicine ecosystem; DueCare is the broader IoMT device portfolio; MediRun is a separate Hospital Management System.
Clear separation prevents product confusion.
The ecosystem is connected by ownership and health-technology strategy, but each product has a distinct role and operating boundary.
Ambulant+
The core Contactless Medicine platform for patient access, clinician workflows, connected clinical devices, MedReach diagnostics, CarePort fulfilment and InsightCore intelligence.
CarePort
The Ambulant+ pharmacy and delivery-rider operations layer for medicine continuity, dispatch, handover, tracking and proof-of-delivery.
MedReach
The Ambulant+ diagnostics operations layer for home phlebotomy, specimen collection, laboratory coordination and result-routing workflows.
InsightCore
The Ambulant+ intelligence layer for programme visibility, operational reporting, adherence signals, risk trends and workflow performance.
DueCare
Cloven Technology Impilo’s broader range of Internet of Medical Things devices beyond the devices currently integrated into Ambulant+.
MediRun
A Hospital Management System owned by Cloven Technology Impilo. MediRun is separate from the Ambulant+ Contactless Medicine ecosystem.
CarePort, MedReach and InsightCore are part of the Ambulant+ Contactless Medicine operating model.
DueCare covers the broader range of IoMT devices beyond the devices integrated into Ambulant+.
MediRun is a Hospital Management System and should not be presented as part of Ambulant+.
Enter the right Ambulant+ workspace.
Ambulant+ separates public information from protected workspaces, giving patients, clinicians, pharmacies, diagnostics teams, clients and administrators a role-appropriate route into the platform.